Replacing Ian McDonald as head of drug discovery at Structural Bioinformatics is Ruth Nutt, who will be the company''s new acting head of drug discovery and a member of its scientific advisory board. She will oversee all drug discovery efforts and report to David Muth, the company''s president and chief operating officer.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.